Blog (old)

9
Oct

Introducing SSDP’s Yes on 4 Campaign Educators

Yes on 4, The Natural Psychedelic Substances Act, is a citizen-led ballot question that will enable therapeutic access to natural psychedelic medicines that show promise in treating mental health conditions in Massachusetts. The measure creates a regulated framework for supervised use with trained facilitators at licensed psychedelic therapy centers and removes criminal penalties for limited personal use. SSDP’s Gina Giorgio

Read more

8
Oct

Sign Up to Support SSDP and Science at Historic Public Hearing on DOI and DOC

SSDP is leading the fight to keep psychedelic research legal! The DEA wants to add two important research chemicals—2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC)—to Schedule I of the Controlled Substances Act, despite decades of safe usage in labs and no history of abuse. DOI and DOC’s current status as unscheduled compounds has made them de facto tools for researchers studying serotonin

Read more

7
Oct

Investors Hangout: DEA Witness Denial Sparks Outcry Among Advocates

Published on October 7, 2024 in Investors Hangout by Owen Jenkins. The Drug Enforcement Administration (DEA) has caused quite a stir by denying testimony from important witnesses just before scheduled hearings on the potential classification of two psychedelic compounds, 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC). This decision has led to significant backlash from advocates, most notably the Students for Sensible Drug Policy

Read more

7
Oct

Benzinga: DEA Rejects Witnesses For November Hearings On Two Psychedelic Compounds, Advocates Push Back

Coverage on October 7, 2024 in Benzinga by Juan Spínelli. “What is the DEA so scared of that these leading scientists must be muzzled?” asked Robert Rush, a Denver-based attorney representing SSDP. He criticized the agency for attempting to block testimony from some of the world’s foremost experts in neuroscience and pharmacology. Read more in Benzinga here.

4
Oct

Green Market Report: DEA rejects speakers for November hearings on two psychedelic compounds

We are grateful to Debra Borchardt from Green Market Report for her coverage on the DOI/DOC hearings published on October 4, 2024. “What is the DEA so scared of that these leading scientists must be muzzled?” said Robert Rush, a Denver-based attorney who is working hand-in-hand with SSDP to keep research using DOI and DOC legal. “By trying to silence

Read more

4
Oct

Filter: DEA Bids to Exclude Expert Witnesses From Psychedelics-Ban Hearing

Special thanks to Jack Gorsline from Filter Magazine for a deeper look into the DEA’s response to our expert witnesses for the DOI and DOC hearing. Published on October 4, 2024. “We have assembled a world-class international group of behavioral and molecular pharmacologists, chemists, neuroscientists, and a former Government Advisor on psychoactive drugs,” added SSDP’s Elijah Ullman, who is himself pursuing

Read more

4
Oct

Marijuana Moment: DEA Seeks To Block Experts From Giving ‘Incompetent’ Testimony At Hearing On Proposed Psychedelics Ban

DOI and DOC’s current status as unscheduled compounds has made them de facto tools for researchers studying serotonin receptors. They have featured in more than 900 research articles and show promise for pain management, combatting anxiety and depression, and preventing overdose. Scheduling DOI and DOC would create serious impediments to potentially life-saving research, and yet SSDP is the only drug

Read more

4
Oct

DEA SILENCES SCIENTISTS; STUDENT GROUP PUSHES BACK AGAIN

Contact:Gina Giorgio Director of Strategy and DevelopmentStudents for Sensible Drug Policygina@ssdp.org DEA SILENCES SCIENTISTS; STUDENT GROUP PUSHES BACK AGAIN Since 2022, Students for Sensible Drug Policy (SSDP) Has Led the Fight to Prevent the DEA From Scheduling DOI and DOC, Which Would Create Serious Impediments to Potentially Life-Saving Research [Washington D.C., October 3, 2024] —  Students for Sensible Drug Policy (SSDP)—a

Read more

27
Sep

SSDP Partners with Overdrive Defense To Make Drug Checking Cool

Over 100,000 people died from overdose in the United States last year. Many of these overdoses were caused by Fentanyl, a synthetic opioid that is up to 50 times stronger than heroin and 100 times stronger than morphine that has exacerbated the overdose epidemic caused by the War on Drugs. These deaths were preventable—the criminalization and stigmatization of drugs and

Read more

20
Sep

Meet Deandré Smith, SSDP’s New Director of Chapter Relations and Strategic Expansion 

SSDP is pleased to welcome Deandré Smith as our new Director of Chapter Relations and Strategic Expansion. Deandré has experienced SSDP through many different lenses—as an SSDP Ambassador at Florida Agricultural and Mechanical University (FAMU), where he is a Doctor of Pharmacy candidate, as an alum of SSDP’s HBCU Ambassador program and Psychedelic Pipeline, and as Vice Chair of our

Read more

17
Sep

Reimagining the Drug War Amid Rising Coca Cultivation in Central America – WOLA

This podcast episode features Kendra McSweeney and Fritz Pinnow, part of a team investigating a new trend: the emergence of coca cultivation in Central America. McSweeney, a professor of geography at Ohio State University, has research human-environment interactions, cultural and political ecology, conservation and development, resilience, demography, and land use/cover change. Pinnow is a Honduras-based journalist and documentary photographer specializing in illicit economies,

Read more

17
Sep

Earthstar’s Intentional Music Fest Takes Center Stage in Joshua Tree – Yahoo Finance

SSDP is excited to be a part of Earthstar Festival, a plant medicine unconference meets music festival taking place in the heart of Joshua Tree, California. Learn more here.

11
Sep

Expanding Minds – The Assembly

SSDP was mentioned in The Assembly’s article discussing how North Carolina has been part of a national movement to broaden the use of MDMA to treat post-traumatic stress disorder and quoted SSDP’s Gina Giorgio. Last year, the Health House Standing Committee of the N.C. General Assembly approved the Breakthrough Therapies Research and Advisory Act unanimously, which would allocate $5.4 million to support

Read more

4
Sep

Shape the Future of Drug Education With SSDP

We are excited to announce our new Drug Education Committee, and are looking for passionate and skilled individuals to join us in shaping the future of drug education and harm reduction on college campuses and in school systems nationwide!  Apply to Join What We’re Doing: By joining the SSDP Drug Education Committee, you’ll get the opportunity to support the following

Read more

30
Aug

SSDP Features in The Microdose

The Microdose is an independent journalism newsletter supported by the U.C. Berkeley Center for the Science of Psychedelics with over 45,000 subscribers Scheduling DOI and DOC would create serious impediments to potentially life-saving research, and yet SSDP is the only drug policy organization currently fighting to keep DOI and DOC off the Controlled Substances Act. The future of psychedelics rests

Read more

29
Aug

Yes on 4: Massachusetts will vote to create legal access to natural psychedelics this fall

Yes on 4: Massachusetts will vote to create legal access to natural psychedelics this fall After the recent decision by the FDA to not approve MDMA for the treatment of PTSD, it’s clear that the route to legal access for psychedelics will run through the states for the foreseeable future.  Fortunately, there’s growing momentum behind state-focused efforts to legalize psychedelics.

Read more

23
Aug

Victory for Harm Reduction in Pennsylvania!

Susquehanna University SSDP Secures University Approval for Naloxone Distribution on Campus

20
Aug

DEA SCHEDULES FIRST-EVER TWO WEEK PUBLIC HEARING ON PSYCHEDELICS

Contact:Gina Giorgio Director of Strategy and DevelopmentStudents for Sensible Drug Policygina@ssdp.org DEA SCHEDULES FIRST-EVER TWO WEEK PUBLIC HEARING ON PSYCHEDELICS IN ONGOING STUDENT-LED EFFORT TO PREVENT THE WRONGFUL SCHEDULING OF VITAL RESEARCH CHEMICALS WITH PROMISING MEDICAL POTENTIAL Since 2022, Students for Sensible Drug Policy (SSDP) Has Led the Fight to Prevent the DEA From Scheduling DOI and DOC, Which Would Create

Read more

6
Aug

Welcome Community College of Denver (SSDP at CCD)!

SSDP’s Staff is excited to announce that a new chapter has formed at the Community College of Denver (CCD)! SSDP is a natural fit for the CCD student body both because of its proximity to Denver (which has earned a reputation as the unofficial capital of legal cannabis), and because one of the flagship programs at CCD is the Cannabis

Read more

24
Jul

SSDP Public Comment on Marijuana Descheduling Quoted in Marijuana Moment

While SSDP commends the Department of Justice for taking a much-needed step towards ending federal marijuana prohibition, rescheduling marijuana as a Schedule III drug simply is not sufficient.

24
Jul

STUDENT-LED NONPROFIT FIGHTS THE DEA IN COURT IN EFFORT TO PRESERVE ACCESS TO VITAL RESEARCH CHEMICALS WITH PROMISING MEDICAL POTENTIAL

Students for Sensible Drug Policy (SSDP) is the Only Drug Policy Organization Actively Working to Prevent the DEA From Scheduling DOI and DOC, Which Would Create Serious Impediments to Potentially Life-Saving Research

23
Jul

SSDP FIGHTS THE DEA IN COURT TO PRESERVE RESEARCH CHEMICALS

Contact:Kat MurtiExecutive DirectorStudents for Sensible Drug Policykat@ssdp.org STUDENT-LED NONPROFIT FIGHTS THE DEA IN COURT IN EFFORT TO PRESERVE ACCESS TO VITAL RESEARCH CHEMICALS WITH PROMISING MEDICAL POTENTIAL Students for Sensible Drug Policy (SSDP) is the Only Drug Policy Organization Actively Working to Prevent the DEA From Scheduling DOI and DOC, Which Would Create Serious Impediments to Potentially Life-Saving Research [Washington

Read more

22
Jul

SSDP Submits Public Comment on Marijuana Rescheduling to Federal Register

Students for Sensible Drug Policy urges the Department of Justice to not just reschedule marijuana as a Schedule III drug, but to remove it from the Controlled Substances Act entirely (“descheduling”).  While SSDP commends the Department of Justice for taking a much-needed step towards ending federal marijuana prohibition, rescheduling marijuana as a Schedule III drug simply is not sufficient. Schedule

Read more

13
Jul

Rowan University SSDP Wins Chapter of the Year!

In recognition of their tireless efforts and amazing achievements, SSDP is proud to name Rowan SSDP Chapter of the Year!

12
Jul

10 Days to Decriminalize 🍁

Every 31 seconds, another person is arrested for a drug offense in the United States.

It takes just 30 seconds to submit a public comment calling for marijuana decriminalization using our tool.